Categories: aggregated

The Trillion-Dollar Question: Why Big Pharma’s Monopoly Fights to Keep Cannabis Illegal?

A recent study published in Health Economics provides a smoking gun that prohibition apologists would prefer you ignore. Researchers found that cannabis legalization reduces prescription drug spending by approximately 6% in small group insurance markets, with the effect growing stronger over time. Translation: when people can legally access cannabis, they spend less money on Big Pharma’s products.

Jason

Share
Published by
Jason

Recent Posts

A Beginner’s Guide to Low-Dose Social Drinking

Low-dose THC beverages typically contain somewhere between 2 and 5 mg of THC per serving.…

4 hours ago

6 Surprising Truths Cannabis Actually Teaches You About Yourself

A few dozen strangers answered one question, and here's what they told me. Cannabis rarely…

1 day ago

DEA Hearing Bombshell: Marijuana Rescheduling Rules Never Existed

Federal officials admitted under oath at the DEA marijuana rescheduling hearing that the 54-year-old test…

2 days ago

Why Trump Lost the 2026 Midterms: The 2028 Cannabis & Hemp Playbook

Discover why Donald Trump lost the 2026 midterms, how the hemp and cannabis industries survived…

3 days ago

Dr. Siegel’s Marijuana Math Doesn’t Add Up: Why the Data on Parents, Teens, and Cannabis Tells a Different Story

On October 29, Fox News ran a column by Dr. Marc Siegel, the network’s senior medical…

5 days ago

The Truth About Medical Marijuana: Why Cannabis Is Neither a Miracle Nor a Menace

Is cannabis a miracle cure or a gateway to ruin? We break down the latest…

6 days ago